Yellowknife Public Health moving to join downtown primary care - Cabin Radio
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Yellowknife Public Health is relocating. Starting next week it’ll be based in the same downtown location as some primary care services, the NWT’s health authority says.
The public health unit starts operations on the main floor of YK Centre East on Tuesday, October 13. Primary care and lab services already operate from the same building.
This article is an excerpt. To read the full content, visit the original source. Cabin Radio
Related articles
Yellowknife sexual health clinic begins weekly walk-ins - Cabin Radio
Yellowknife’s sexual health clinic will start accepting walk-in clients every Wednesday in a trial designed to improve access to its services. The clinic, at the city’s primary care centre on 48 Street, will take walk-ins from 9am-12pm and 1-3pm each Wednesday.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!